Trials / Completed
CompletedNCT01321515
Bioequivalency Study of Famciclovir 500 mg Tablets Under Fasted Conditions
A Single Dose, 2-Period, 2-Treatment, 2-Way Crossover Bioequivalency Study of Famciclovir Tablets Under Fasting Conditions
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Roxane Laboratories · Industry
- Sex
- All
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
The objective of this study was to prove the bioequivalence of Famciclovir 500 mg Tablets under fasting conditions.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | famciclovir | 500 mg tablet |
Timeline
- Start date
- 2007-07-01
- Primary completion
- 2007-07-01
- Completion
- 2007-07-01
- First posted
- 2011-03-23
- Last updated
- 2018-01-23
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT01321515. Inclusion in this directory is not an endorsement.